results from the engot-ov16/nova trial: efficacy and safety of niraparib in ovarian cancer
Published 7 years ago • 1.1K plays • Length 9:24Download video MP4
Download video MP3
Similar videos
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:50
niraparib as maintenance for platinum-sensitive ovarian cancer - results from engot-ov16/nova trial
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
1:14
next steps for niraparib for ovarian cancer following on from the engot-ov16/nova trial
-
2:26
trial design of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
2:17
combination therapy to treat ovarian cancer: promising results from the ananova trial
-
4:34
niraparib in newly diagnosed advanced ovarian cancer: prima results
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
3:11
the avanova study: niraparib and bevacizumab for ovarian cancer
-
10:44
efficacy and safety of olaparib and niraparib in switch maintenance
-
1:44
the delivery of niraparib and rucaparib as ovarian cancer treatment options
-
3:04
phase ii results for niraparib in heavily pretreated patients with ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients